Collection: Neurosciences & Neurology & Psychiatry in 2025How to Cite: Wang N, Tao Y, Yang Y, Jin Y, Zhang H, Li C, Qin H, Chen Q. Disrupting the activity of endogenous gas neurotransmitters: a therapeutic strategy using engineered metal-organic frameworks for cancer. Med Gas Res. 2025 Mar 1;15(1):142-144. doi: 10.4103/mgr.MEDGASRES-D-24-00046. Epub 2024 Sep 25. PMID: 39436187 Oxygen-ozone therapy for myocardial ischemic stroke and cardiovascular disorders How to Cite: Pandolfi S, Chirumbolo S, Franzini M, Tirelli U, Valdenassi L. Oxygen-ozone therapy for myocardial ischemic stroke and cardiovascular disorders. Med Gas Res. 2025 Mar 1;15(1):3643. doi: 10.4103/mgr.MEDGASRES-D-23-00013. Epub 2024 Aug 31. PMID: 39217427 Ozone: complicated effects in central nervous system diseases How to Cite: Zhang X, Wang SJ, Wan SC, Li X, Chen G. Ozone: complicated effects in central nervous system diseases. Med Gas Res. 2025 Mar 1;15(1):44-57. doi: 10.4103/mgr.MEDGASRES-D-24-00005. Epub 2024 Oct 2. PMID: 39436168 Effects of ozone treatment on chemotherapy-induced peripheral neuropathy: a promising research area How to Cite: Clavo B, Cánovas-Molina A, García-Lourve C, Cazorla-Rivero S, Federico M, Rodríguez-Esparragón F. Effects of ozone treatment on chemotherapy-induced peripheral neuropathy: a promising research area. Med Gas Res. 2025 Jun 1;15(2):195-197. doi: 10.4103/mgr.MEDGASRES-D-24-00074. Epub 2025 Jan 18. PMID: 40070187 Why provide 40 sessions of hyperbaric oxygen therapy to patients with traumatic brain injury? How to Cite: Borlongan CV, Hadanny A. Why provide 40 sessions of hyperbaric oxygen therapy to patients with traumatic brain injury? Med Gas Res. 2025 Mar 1;15(1):132-133. doi: 10.4103/mgr.MEDGASRES-D-24-00029. Epub 2024 Sep 25. PMID: 39436183 Hyperbaric oxygen for moderate-to-severe traumatic brain injury: outcomes 5-8 years after injury How to Cite: Zhang Z, Li Z, Li S, Xiong B, Zhou Y, Shi C. Hyperbaric oxygen for moderate-to-severe traumatic brain injury: outcomes 5-8 years after injury. Med Gas Res. 2025 Mar 1;15(1):156-163. doi: 10.4103/mgr.MEDGASRES-D-24-00018. Epub 2024 Sep 25. PMID: 39324933 How to Cite: Marsico AL, da Silva-Tomaeli SC, Marques PSB, Feres O, Lopes LS, Sbragia L. Hyperbaric oxygen therapy alleviates intestinal and brain damage in experimental necrotizing enterocolitis. Med Gas Res. 2025 Dec 1;15(4):471-477. doi: 10.4103/mgr.MEDGASRES-D-24-00108. Epub 2025 Apr 29. PMID: 40300882 How to Cite: Wang H, Li Y, Shen S, Li X, Li C, Li Y, Chen H, Ren C, Song Y, Tang Y, Dong H, Zhao M, Zhang S, Wang H. Hyperbaric oxygen therapy for paroxysmal sympathetic hyperactivity syndrome after brain injury: a multicenter, retrospective cohort study. Med Gas Res. 2025 Jun 1;15(2):327-331. doi: 10.4103/mgr.MEDGASRES-D-24-00077. Epub 2024 Dec 7. PMID: 39829168 How to Cite: Cai T. Hyperbaric oxygen therapy as an adjunt treatment for glioma and brain metastasis: a literature review. Med Gas Res. 2025 Sep 1;15(3):420-426. doi: 10.4103/mgr.MEDGASRES-D-24-00096. Epub 2025 Feb 7. PMID: 39923138 How to Cite: Kaufman MJ, Meloni EG. Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders. Med Gas Res. 2025 Jun 1;15(2):234-253. doi: 10.4103/mgr.MEDGASRES-D-24-00063. Epub 2025 Jan 13. PMID: 39812023 How to Cite: Maiese K. Biological gases, oxidative stress, artificial intelligence, and machine learning for neurodegeneration and metabolic disorders. Med Gas Res. 2025 Mar 1;15(1):145-147. doi: 10.4103/mgr.MEDGASRES-D-24-00059. Epub 2024 Oct 2. PMID: 39436188 How to Cite: Liu Y, Shen T, Li Q, Yu X, Liu Y, Zhou C, Han J, Zhu Y. Various gases for the treatment of neuropathic pain: mechanisms, current status, and future perspectives. Med Gas Res. 2025 Dec 1;15(4):488-495. doi: 10.4103/mgr.MEDGASRES-D-24-00161. Epub 2025 Apr 29. PMID: 40300884 Direct generation of 1O2 in living tissues for the treatment of brain diseases How to Cite: Semyachkina-Glushkovskaya O. Direct generation of 1O2 in living tissues for the treatment of brain diseases. Med Gas Res. 2025 Jun 1;15(2):208-209. doi: 10.4103/mgr.MEDGASRES-D-24-00092. Epub 2025 Jan 18. PMID: 40070193 How to Cite: Rubio-Zarapuz A, Parraca JA, Tornero-Aguilera JF, Clemente-Suárez VJ. Unveiling the link: exploring muscle oxygen saturation in fibromyalgia and its implications for symptomatology and therapeutic strategies. Med Gas Res. 2025 Mar 1;15(1):58-72. doi: 10.4103/mgr.MEDGASRES-D-24-00013. Epub 2024 Apr 21. PMID: 39436169 How to Cite: Tang L, Wen D, Huang Z, Lei X, Li X, Zhu Y, Hai S, Guo Z. 10% carbon dioxide improves cognitive function after subarachnoid hemorrhage in rats: inhibiting neuronal apoptosis through the PI3K/AKT signaling pathway. Med Gas Res. 2025 Sep 1;15(3):391-397. doi: 10.4103/mgr.MEDGASRES-D-24-00116. Epub 2025 Mar 12. PMID: 40072264 Multifaceted role of nitric oxide in vascular dementia How to Cite: Yang Y, Ma K, Li S, Xiong T. Multifaceted role of nitric oxide in vascular dementia. Med Gas Res. 2025 Dec 1;15(4):496-506. doi: 10.4103/mgr.MEDGASRES-D-24-00158. Epub 2025 Apr 29. PMID: 40300885 How to Cite: Lei MK, Ong ML, Simons RL, Beach SRH. Biological aging and its association with serum neurofilament light chain levels in middle-aged African Americans: a prospective observational study. Aging Adv. 2025;2(1):1-8. https://doi.org/10.4103/AGINGADV.AGINGADV-D-24-00021 Neurovascular unit in ischemic stroke in older adults: a narrative review How to Cite: Wang C, Yang Y, Xiong T, Li S. Neurovascular unit in ischemic stroke in older adults: a narrative review. Aging Adv. 2025;2(1):29-39. https://doi.org/10.4103/AGINGADV.AGINGADV-D-24-00031 Oleuropein: a narrative review on its role in neurodegenerative diseases How to Cite: Riquelme, Constanza V; Pando, María E. Oleuropein: a narrative review on its role in neurodegenerative diseases. Aging Advances 2(2):75-83. https://doi.org/10.4103/AGINGADV.AGINGADV-D-25-00002 Effects of tropicamide on catalepsy and motor function in a mouse model of Parkinson’s disease How to Cite: Corrêa ÉMS, Souza AS, Christofoletti G. Effects of tropicamide on catalepsy and motor function in a mouse model of Parkinson’s disease. Aging Adv. 2025;2(3):89-93. https://doi.org/10.4103/AGINGADV.AGINGADV-D-25-00007 population: a narrative review How to Cite: Alshanberi AM, Ansari SA. Awareness level and management plans for tackling common neurological disorders among the Saudi older population: a narrative review. Aging Adv. 2025;2(3):103-107. https://doi.org/10.4103/AGINGADV.AGINGADV-D-25-00005 How to Cite: Shu Q, Liu R, Pang X, Huang X, Pang C. The role of microtubule proteins TUBB2A, TUBB3, and TUBB4B in neuronal dysfunction in Alzheimer’s disease: a bioinformatics analysis. Aging Adv. 2025;2(4):139-146. https://doi.org/10.4103/AGINGADV.AGINGADV-D-25-00026 Gamma entrainment as a therapeutic modality for the aging brain: a narrative review How to Cite: Chen B. Gamma entrainment as a therapeutic modality for the aging brain: a narrative review. Aging Adv. 2025;2(4):155-159. https://doi.org/10.4103/AGINGADV.AGINGADV-D-25-00017 How to Cite: Aborode AT, Emmanuel OA, Onifade IA, Olotu E, Otorkpa OJ, Mehmood O, Abdulai SI, Jamiu A, Osinuga A, Oko CI, Fakorede S, Mangdow M, Babatunde O, Olapade Z, Victoria AG, Salami A, Usman IA, Agboli VI, Adesola RO. The role of machine learning in discovering biomarkers and predicting treatment strategies for neurodegenerative diseases: A narrative review. NeuroMarkers. 2025;1. https://doi.org/10.1016/j.neumar.2024.100034 How to Cite: Xu XY, Chen QQ, Li S, Xiong TQ. Peroxisome proliferator-activated receptors as biomarkers in cerebrovascular diseases: A narrative review. NeuroMarkers. 2025;1. https://doi.org/10.1016/j.neumar.2024.100035 Role of the amygdala and possible biomarkers in psychiatric disorders How to Cite: Flores G, Reyes-Lizaola S, Aguilar-Hernández L, Gil-Velazco A, Tendilla-Beltrán H, Morales-Medina JC. Role of the amygdala and possible biomarkers in psychiatric disorders. NeuroMarkers. 2025;1. https://doi.org/10.1016/j.neumar.2024.100032 How to Cite: Marksteiner J, Humpel C. Glial fibrillary acidic protein as a biomarker for diagnosis of Alzheimer’s disease in cerebrospinal fluid, plasma and saliva measured with Lumipulse technology: a narrative review. NeuroMarkers. 2025;1. https://doi.org/10.1016/j.neumar.2025.100038 How to Cite: Zhang GJ, Xu DD, Bu SY, Li L, Jiao J, Shi YC, Xu Y, Kong Y, Zhang ZJ. RNA high-throughput sequencing and clinical outcome validation indicate that long non-coding RNAs are biomarkers in the peripheral blood of patients with major depressive disorder. NeuroMarkers. 2025;4. https://doi.org/10.1016/j.neumar.2025.100114 How to Cite: Fan Y, Hu Z, Wan JJ, Yang YR, Huang SJ, Chen FZ, Zhong M, Zhou XY, Liu J, Li YY. Cataracts as a potential non-motor marker for Parkinson's disease: An observational study based on UK biobank data. NeuroMarkers. 2025;4. https://doi.org/10.1016/j.neumar.2025.100112 How to Cite: Kumar P, Chaudhary B, Devi S, Dubey G, Chatterjee A, Sharma D, Gupta MM. Therapeutic applications and strategies of neurobiomarkers in neurological disorders: A narrative review. NeuroMarkers. 2025;4. https://doi.org/10.1016/j.neumar.2025.100113 How to Cite: do Nascimento Silva J, Rodrigues BA, Kawamoto EM. Neurogenesis markers in brain aging and their serotonergic modulation by physical exercise: A narrative review. NeuroMarkers. 2025;4. https://doi.org/10.1016/j.neumar.2025.100110 How to Cite: Neto OP, Pinho TOR. Grip force variability and deep learning: A cross-sectional study of a novel biomarker for early detection of Parkinson's disease. NeuroMarkers. 2025;3. https://doi.org/10.1016/j.neumar.2025.100106 How to Cite: Teixeira IMM, Costa MDR, Filho HLP, Duque BR, Pinheiro NML, Menezes RRPPB, Martins AMC, Sampaio TL. Apolipoprotein E genotype as a biomarker in late-onset Alzheimer’s disease: A narrative review of the influence of genetic factors on molecular structure. NeuroMarkers. 2025;3. https://doi.org/10.1016/j.neumar.2025.100095 How to Cite: Braudeau J, Souchet B, Streel E. Optimizing Alzheimer's diagnosis and precision medicine: A narrative review unlocking the potential of multiomics markers. NeuroMarkers. 2025;3. https://doi.org/10.1016/j.neumar.2025.100107 Biomarkers in autoimmune myasthenia gravis: A narrative review How to Cite: De León AM. Biomarkers in autoimmune myasthenia gravis: A narrative review. NeuroMarkers. 2025;3. https://doi.org/10.1016/j.neumar.2025.100094 How to Cite: Torres-Rico M, Arasmou-Idrovo MS, Marín-Rodríguez B, Pascual-Guerra J. Fractal dimension reveals cellular morphological changes as early biomarkers in neurodegenerative diseases: A narrative review. NeuroMarkers. 2025;3. https://doi.org/10.1016/j.neumar.2025.100108 How to Cite: dos Santos JCC. Role of gut-microbiome-brain axis in neurodegenerative diseases: A narrative review of mechanisms, therapeutics, and emerging perspectives. NeuroMarkers. 2025;3. https://doi.org/10.1016/j.neumar.2025.100111 Early detection of autism with the help of biomarkers: A narrative review How to Cite: Puri A. Early detection of autism with the help of biomarkers: A narrative review. NeuroMarkers. 2025;3. https://doi.org/10.1016/j.neumar.2025.100109 How to Cite: Yang B, Han YQ, Shi MQ, Lu K, Wang Y, Gao ZQ, Zhang Y, Qu MH, Chen ZS, Waye MMY, Wang YB. The value of ITGA and ITGB superfamily genes as biomarkers for the early diagnosis and prognosis of gliomas: A retrospective observational study based on the GEPIA and CGGA databases. NeuroMarkers. 2025;2. https://doi.org/10.1016/j.neumar.2025.100039 How to Cite: Zha XW. Identification of novel biomarkers and immune characteristics of spinal cord injury based on comprehensive bioinformatic analysis: A retrospective observational study. NeuroMarkers. 2025;2. https://doi.org/10.1016/j.neumar.2025.100077 How to Cite: Ayano G, Zena D, Gizachew Y, Tsegay L. Neurobiomarkers of psychiatric disorders in children and adolescents and their significance for diagnosis and precision medicine: A narrative review. NeuroMarkers. 2025;2. https://doi.org/10.1016/j.neumar.2025.100040 How to Cite: Agustini D, Sabloak R, Hasan S, Umar TP. The role of fusion proteins as biomarkers and therapeutic agents for Alzheimer's disease: A narrative review. NeuroMarkers. 2025;2. https://doi.org/10.1016/j.neumar.2025.100041 How to Cite: Parikh D, Shah M. Values of epigenetic markers in Parkinson's disease as biomarkers and therapeutic targets: A narrative review. NeuroMarkers. 2025;2. https://doi.org/10.1016/j.neumar.2025.100037 Blood biomarkers for clinical applications in Alzheimer's disease: A narrative review How to Cite: Li HJ, Wang Z. Blood biomarkers for clinical applications in Alzheimer's disease: A narrative review. NeuroMarkers. 2025;2. https://doi.org/10.1016/j.neumar.2025.100078 How to Cite: Yang L, Zheng PT, Huang C, Gao CH, Pang XP, Liu H, Wei YY, Pang CY. Identifying Alzheimer's disease-associated genes related to N6-methyladenosine modification as potential biomarkers through correlation analysis: A retrospective observational study. NeuroMarkers. 2025;1. https://doi.org/10.1016/j.neumar.2025.100036 Neuroprotective effects of remote ischemic conditioning in acute ischemic stroke: a meta-analysis How to Cite: Gao Y, Zhang X, Xu H, Zhang P. Neuroprotective effects of remote ischemic conditioning in acute ischemic stroke: a meta-analysis. Regen Med Rep. 2025;2(1):1-6. https://doi.org/10.4103/REGENMED.REGENMED-D-24-00025 How to Cite: Segasby T, Sanaei R, Aleksejenko N, Mamad O, Henshall DC, Floudas A, Heller JP. Aberrant hippocampal neurogenesis produces glial cells in epilepsy: new targets for regenerative medicine. Regen Med Rep. 2025;2(1):7-14. https://doi.org/10.4103/REGENMED.REGENMED-D-24-00008 How to Cite: Zha X. Challenges and opportunities for repairing the injured spinal cord: inflammation, regeneration, and functional reconstruction. Regen Med Rep. 2025;2(1):36-44. https://doi.org/10.4103/REGENMED.REGENMED-D-24-00027 How to Cite: Tashiro, Syoichi. Further treatment strategies to enhance regenerative rehabilitation for cell therapy in chronic spinal cord injury: a concise review of preclinical studies. Regen Med Rep 2(2):67-71. https://doi.org/10.4103/REGENMED.REGENMED-D-25-00004 How to Cite: Chen S, Pei H, Liang H, Geng J, Chen W, Zong Y, Zhao Y, Du R, He Z. Active ingredients derived from plants, animals, and fungi promote central nervous system regeneration: a narrative review. Regen Med Rep. 2025;2(3):121-129. https://doi.org/10.4103/REGENMED.REGENMED-D-25-00017 How to Cite: Pays E. Inflammation-linked apolipoprotein-L activities: immunity control, mitochondrial repair, pathogen resistance, and disease induction. Regen Med Rep. 2025;2(4):161-168. https://doi.org/10.4103/REGENMED.REGENMED-D-25-00027 How to Cite: Naffaa MM. Induced pluripotent stem cell models for advancing neurodevelopmental disorder research and regenerative medicine: a narrative review. Regen Med Rep. 2025;2(4):169-184. https://doi.org/10.4103/REGENMED.REGENMED-D-25-00013 How to Cite: Banday AH. Harnessing the immune system and developing targeted vaccines: overall strategies of leveraging the body’s natural defense mechanisms to enhance cancer treatment. Regen Med Rep. 2025;2(4):185-192. https://doi.org/10.4103/REGENMED.REGENMED-D-25-00011 How to Cite: Zhang XD, Teng C, Bai X, Baum B, Clifton M, Bay S. Optimizing skin regeneration following invasive dermatological procedures with NDZnO: real-world case studies. Regen Med Rep. 2025;2(4):137-142. https://doi.org/10.4103/REGENMED.REGENMED-D-25-00015 New horizons in regenerative medicine: photostimulation of adipose tissue How to Cite: Valente, Denis Souto. New horizons in regenerative medicine: photostimulation of adipose tissue. Regen Med Rep 2(2):72-75. https://doi.org/10.4103/REGENMED.REGENMED-D-25-00001 How to Cite: Chao T, Zhao J, Gao R, Wang H, Guo J, Gao Z, Wang Y. Exosome surface modification and functionalization: a narrative review of emerging technologies and their application potential in precision medicine. Adv Technol Neurosci. 2025;2(1):27-33. https://doi.org/10.4103/ATN.ATN-D-24-00025 How to Cite: Cui Z, Wang X, Zhang Q, Li L, Liu F. Liquid–liquid phase separation technologies of α-synuclein governed by its C-terminus via electrostatic interactions: unveiling potential therapeutic targets for Parkinson’s disease. Adv Technol Neurosci. 2025;2(1):1-8. https://doi.org/10.4103/ATN.ATN-D-24-00027 Three-dimensional cell culture technologies in the study of Alzheimer’s disease: a narrative review How to Cite: Chacón PEA, Irineo-Moreno V, Loera-Valencia R. Three-dimensional cell culture technologies in the study of Alzheimer’s disease: a narrative review. Adv Technol Neurosci. 2025;2(2):85-90. https://doi.org/10.4103/ATN.ATN-D-24-00016 How to Cite: Chen, Xudong; Zhuang, Jianyong; Gao, Zhenman. Synchronization for chaotic neural networks based on sampled data: A novel neuroscience technology using time-squared augmented Lyapunov functional.Adv Technol Neurosci. 2025;2(4):152-160. https://doi.org/10.4103/ATN.ATN-D-25-00015 How to Cite: Zha X. Bioinformatics analysis techniques identify the ferroptosis-related gene MYC as a potential therapeutic target for spinal cord injury: an observational study based on the GEO database. Adv Technol Neurosci. 2025;2(2):59-71. https://doi.org/10.4103/ATN.ATN-D-24-00026 How to Cite: Zhou S, Yang Y, Qiu N, Yang T. The role of long non-coding RNAs in angiogenesis in ischemic stroke: new perspectives based on advanced techniques in neuroscience. Adv Technol Neurosci. 2025;2(2):77-84. https://doi.org/10.4103/ATN.ATN-D-24-00030 Exosome-based therapy for spinal cord injury: a narrative review How to Cite: Zha X. Exosome-based therapy for spinal cord injury: a narrative review. Adv Technol Neurosci. 2025;2(3):128-134. https://doi.org/10.4103/ATN.ATN-D-25-00001 How to Cite: Yao X, Zhou Y, Liu Y, Jie J, Wan X, Yang P. Engineered exosome-based treatment for peripheral nerve regeneration: a narrative review of clinical prospects. 2025;2(3):135-143. https://doi.org/10.4103/ATN.ATN-D-25-00009
How to Cite: Zhong, Hao; Wang, Hongda; Huang, Boya; Liu, Song; Song, Zexing; Tang, Yiding; Li, Junjin; Ye, Yuanyuan; Zhou, Mi. Current frontier technologies in spinal cord injury research: A narrative review.Adv Technol Neurosci. 2025;2(4):173-186. https://doi.org/10.4103/ATN.ATN-D-25-00014 |